NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-03 09:22இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Q2 FY27 PAT Rises 24% to ₹26 Cr, EBITDA Margin Expands 300 bps to 15.9%
Indogulf Cropsciences reported a 3% YoY increase in consolidated revenue to ₹256 crore for Q2 FY27, along with a 52% sequential rebound. Operating performance saw significant expansion, with EBITDA rising 27% YoY to ₹41 crore and EBITDA margin expanding 300 bps to 15.9%, driven by an improved product mix. Consolidated PAT rose 24% YoY to ₹26 crore with a 10% PAT margin. For H1 FY27, total income reached ₹424 crore with a PAT of ₹28 crore, reflecting stable profitability despite subdued Kharif season demand.
உச்சம் நம்பிக்கை
என்ன மாறியதுIndogulf Cropsciences announced its consolidated financial results for Q2 and H1 FY27, highlighting double-digit EBITDA and PAT growth despite sluggish Kharif volumes.
ஏன் இது முக்கியம்Demonstrates operating leverage and margin resilience through value-added product mix and cost control, despite broader agrochemical sector headwinds and erratic monsoon conditions.
📅 குறுகிய காலம்The strong operational margin performance and sequential revenue bounce are expected to support sentiment following recent stock weakness.
📈 நீண்ட காலம்The shift toward higher-margin biologicals, export market expansion (LATAM, Africa, Middle East), and adding dry flowable capacity could structurally improve blended realizations.
⚠ அபாய எச்சரிக்கைகள்
Vulnerability of volumes to erratic monsoon patterns and weather vagaries
Dependency on raw material imports (25-30%) exposing margins to supply disruptions and forex movements
👀 கவனிக்க வேண்டியவை
Track the commissioning progress of the ongoing dry flowable plant expansion and monitor Rabi season demand in H2 FY27 to see if high margins can be sustained.
Indogulf Cropsciences Limited announced the outcome of its Board of Directors meeting held on November 02, 2026. The Board considered and approved the un-audited standalone and consolidated financial results for the quarter ended September 30, 2026. Statutory auditors issued a Limited Review Report with an unmodified opinion. The meeting lasted 30 minutes, commencing at 11:00 AM and concluding at 11:30 AM.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுFormal approval and submission of Q2 FY27 quarterly financial results with an unmodified auditor review.
ஏன் இது முக்கியம்Provides official quarterly financial performance metrics for the company, establishing earnings and profitability trends.
Period ended: செப்டம்பர் 30, 2026Meeting duration: 30 minutes (11:00 AM to 11:30 AM)Auditor opinion: un-modified opinion
📅 குறுகிய காலம்Market reaction will depend on the detailed revenue and PAT metrics disclosed in the accompanying financial tables.
📈 நீண்ட காலம்Limited; quarterly earnings review is part of regular regulatory compliance cycles.
👀 கவனிக்க வேண்டியவை
Review the detailed line-item financial statements in Annexure-A to assess revenue and margin trajectory against TTM revenue of Rs 2,919 Cr.
High Court Quashes ₹8.48 Cr GST Demand; IGCL to Receive ~₹8.11 Cr Tax Refund
The Hon'ble High Court of Punjab and Haryana has ruled in favor of Indogulf Cropsciences Limited, quashing a GST show cause notice and order-in-original demanding recovery of ₹6,93,12,901 along with interest of ₹1,54,58,004 (total ~₹8.48 crore). The dispute pertained to an alleged erroneous IGST refund under Rule 96(10). Following this order, the company's prior voluntary deposit of ₹6,56,07,859 (IGST) and ₹1,54,58,004 (interest)—totaling ~₹8.11 crore—will be refunded back to IGCL in due course.
உச்சம் நம்பிக்கை
என்ன மாறியதுHigh Court set aside the ₹8.48 crore tax & interest demand, enabling IGCL to recover ~₹8.11 crore in pre-deposited funds.
ஏன் இது முக்கியம்Eliminates tax litigation risk and provides a liquidity boost of ~₹8.11 crore (equivalent to ~3.6% of FY26 TTM PAT).
Quashed tax demand: ₹6,93,12,901Quashed interest demand: ₹1,54,58,004Refundable voluntary deposit: ₹8,10,65,863Refund as % of TTM PAT: ~3.6%
📅 குறுகிய காலம்Provides positive sentiment by resolving tax ambiguity and confirming upcoming cash recovery.
📈 நீண்ட காலம்Limited structural impact on the ongoing core agrochemicals business.
⚠ அபாய எச்சரிக்கைகள்
Potential appeal or review petition by the GST department in higher judicial forums
👀 கவனிக்க வேண்டியவை
Track the timeline of the actual cash inflow from the tax refund and its recognition in subsequent quarterly financials.
IGCL Q1 FY27: Revenue declines 11% to ₹168.5 Cr; Gross Margins expand to 28%
Indogulf Cropsciences (IGCL) reported a challenging Q1 FY27 with revenue declining 11% YoY to ₹168.5 crore, primarily due to erratic monsoon patterns impacting sales volumes. Despite the top-line contraction, the company achieved a significant gross margin expansion to 28.0% from 22.0% in Q1 FY26, driven by a shift toward differentiated products. However, Net Profit (PAT) fell 38% YoY to ₹2.4 crore, weighed down by higher operating expenses and finance costs. The company remains focused on its 50% capacity expansion at the Sonipat plant, which is slated for completion by Q1 FY2027.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company experienced a double-digit decline in both revenue and net profit for Q1 FY27, although it successfully improved its gross margin profile.
ஏன் இது முக்கியம்The results highlight the company's vulnerability to monsoon patterns while demonstrating a strategic shift toward higher-margin, differentiated agrochemical products to protect profitability.
📅 குறுகிய காலம்The stock may face pressure due to the significant decline in quarterly profits and revenue, reflecting immediate operational headwinds from the monsoon.
📈 நீண்ட காலம்The structural story depends on the successful commissioning of the Sonipat expansion by FY2027 and the ability to scale the B2C and export segments.
👀 கவனிக்க வேண்டியவை
Monitor the execution timeline of the Sonipat plant expansion and the recovery of sales volumes in the upcoming quarters, as Q1 was heavily impacted by weather conditions. Watch for the growth in the 'Biologicals' segment, which currently contributes only 3% to revenue but is a high-margin focus area.
₹1,685 Mn Revenue in Q1 FY27: IGCL Reports 12% QoQ Growth but 38% YoY PAT Decline
Indogulf Cropsciences (IGCL) reported a sequential revenue recovery of 12% to ₹168.5 cr in Q1 FY27, although revenue declined 11% on a year-on-year basis. Profit After Tax (PAT) saw a sharp contraction of 38% YoY, falling to ₹2.4 cr, with net margins thinning to just 1%. A positive operational highlight is the increase in manufacturing capacity utilization to 70%, up from 52% in FY26. The company is currently focusing on its Barwasni facility expansion and diversifying into biologicals to mitigate macro headwinds.
உச்சம் நம்பிக்கை
என்ன மாறியதுIGCL has reported its first quarter results for FY27, showing a recovery in sales volume compared to the previous quarter but a significant decline in profitability compared to the same period last year.
ஏன் இது முக்கியம்The results indicate that while the company is successfully utilizing more of its capacity (70%), it is struggling to convert that into bottom-line growth, with net profit margins remaining extremely low at 1%.
Revenue (Q1 FY27): ₹1,685 millionPAT (Q1 FY27): ₹24 millionCapacity Utilization: 70%YoY PAT Growth: -38%Q1 Revenue vs FY26 Revenue: 6.18%
📅 குறுகிய காலம்The stock may face downward pressure in the short term due to the substantial 38% YoY decline in net profit and the sequential drop in EBITDA margins from 14% to 6%.
📈 நீண்ட காலம்Long-term value depends on the company's ability to scale its biologicals portfolio and successfully complete the Barwasni expansion to achieve economies of scale.
⚠ அபாய எச்சரிக்கைகள்
Low net profit margin (1%)
Significant YoY earnings contraction
High dependency on seasonal monsoon patterns
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution timeline of the Barwasni facility expansion and whether the improved capacity utilization (70%) leads to better operating leverage in the high-growth Q2 period. The significant gap between gross margins (28%) and net margins (1%) warrants a close watch on rising operational and branding expenses.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
IGCL Q1 FY27 Results: Consolidated Revenue at ₹168.5 Cr, PAT down 37.6% YoY to ₹2.4 Cr
Indogulf Cropsciences Limited (IGCL) reported a consolidated revenue of ₹168.54 cr for Q1 FY27, representing an 11% decline from ₹189.37 cr in the same quarter last year. Net profit (PAT) fell significantly by 37.6% YoY to ₹2.41 cr, down from ₹3.87 cr. The company faced severe margin pressure, with total expenses accounting for 98.6% of operational revenue, resulting in a thin Profit Before Tax (PBT) margin of 1.85%. These results highlight the extreme seasonality of the business, where Q1 typically contributes a small fraction of annual revenue.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported its Q1 FY27 financial results, showing a contraction in both revenue and profitability compared to the previous year's corresponding quarter.
ஏன் இது முக்கியம்The results underscore the company's high operational costs and vulnerability to seasonal fluctuations in the agrochemical sector, with current margins leaving little room for error.
📅 குறுகிய காலம்The stock is likely to face negative sentiment in the short term due to the sharp YoY decline in PAT and very thin operating margins.
📈 நீண்ட காலம்Long-term prospects depend on the successful commissioning of the Sonipat expansion by FY2027 and reducing dependency on imported raw materials (currently 25-30%).
⚠ அபாய எச்சரிக்கைகள்
High operational expenses (98.6% of revenue)
Extreme seasonality (Q1 is a minor contributor to annual totals)
Raw material import dependency
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution of the 50% capacity expansion at the Sonipat plant, which is critical for scaling beyond the current seasonal peaks, and track the revenue contribution from the 12 new products launched in H1 FY26.
Indogulf Cropsciences Reports 19% Revenue Growth in FY26; Q4 PAT Rises to INR 12 Crore
Indogulf Cropsciences Limited (IGCL) delivered a resilient performance in FY26, reporting a 19% YoY revenue growth to INR 705 crores. For Q4 FY26, revenue stood at INR 151 crores, up 19% YoY, while PAT also grew 19% to INR 12 crores. However, EBITDA margins for the quarter contracted to 13.5% from 16.5% due to higher employee expenses and volatile input costs. The company is actively expanding its global footprint, recently executing its first shipment to Venezuela and entering markets like Taiwan and Sri Lanka.
முக்கிய அம்சங்கள்
Full-year FY26 revenue grew by 19% YoY to INR 705 crores despite industry-wide challenges like inventory normalization.Q4 FY26 PAT increased by 19% YoY to INR 12 crores, though EBITDA margins dipped to 13.5% due to rising operating costs.Overall manufacturing capacity utilization improved to approximately 52% during the fiscal year.Successfully expanded export operations to Venezuela, Taiwan, and Africa, diversifying geographical risk.The company is scaling its subsidiary, AbhiPrakash Globus Private Limited (AGPL), to deepen rural market penetration.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's margin recovery in upcoming quarters as it navigates raw material volatility and potential El Nino impacts. The shift toward high-margin biologicals and expanded export reach are positive long-term value drivers.
IGCL FY26 Net Profit Rises 19.7% to ₹386.12 Million; New Auditors Appointed
Indogulf Cropsciences Limited (IGCL) reported a steady growth in its financial performance for the fiscal year ended March 31, 2026. Annual revenue from operations increased by 8% to ₹5,966.76 million compared to ₹5,521.84 million in the previous year. Net profit for the full year saw a significant jump of 19.7%, reaching ₹386.12 million. Additionally, the board approved the appointment of new Secretarial, Cost, and Internal Auditors for the upcoming fiscal year to strengthen corporate governance.
முக்கிய அம்சங்கள்
Annual Revenue from operations grew 8% YoY to ₹5,966.76 million in FY26Full-year Net Profit increased to ₹386.12 million from ₹322.40 million in FY25Q4 FY26 standalone revenue stood at ₹1,229.18 million with a net profit of ₹120.97 millionBoard recommended M/s NJ & Associates as Secretarial Auditors for a 5-year term starting FY27Internal and Cost Auditors appointed for FY27 to enhance compliance and audit oversight
👀 கவனிக்க வேண்டியவை
Investors should view the double-digit profit growth and the strengthening of the audit framework as positive indicators of corporate health. The stock remains a watch for sector-specific growth in agro-chemicals.
Indogulf Cropsciences Reports FY26 Growth: 12 New Launches and Expansion to 34+ Countries
Indogulf Cropsciences Limited (IGCL) presented its FY26 performance, highlighting a robust portfolio of 300+ products and a presence in over 34 countries. The company reported a steady increase in manufacturing capacity utilization to 52% in FY26, up from 44% in FY23, across its four facilities. With 189 total registrations and 6 patents, IGCL is aggressively expanding its global footprint, including a strategic entry into the Latin American market with its first shipment to Venezuela.
முக்கிய அம்சங்கள்
Successfully launched 12 new products in FY26 and secured a total of 6 patents for innovative agri-solutions.Expanded global reach to 34+ countries with 189 registrations and 140+ active overseas business partners.Manufacturing capacity utilization improved to 52% in FY26, supported by four facilities including a large-scale unit at Barwasni.Revenue mix for FY26 dominated by Crop Protection (85%), followed by Biologicals (6%) and Plant Nutrients (5%).Strategic focus on high-growth markets like Brazil and Africa, alongside backward integration to reduce dependency on external sourcing.
👀 கவனிக்க வேண்டியவை
Investors should track the company's progress in scaling its high-margin Biologicals segment and the successful ramp-up of the Barwasni facility. The increasing number of global registrations and backward integration efforts suggest a strong competitive position for long-term export growth.
IGCL FY26 PAT Jumps 27% to ₹400 Mn; Revenue Grows 19% on Export Expansion
Indogulf Cropsciences Limited (IGCL) reported a strong financial performance for FY26, with consolidated revenue rising 19% YoY to ₹7,046 million. Net profit (PAT) grew significantly by 27% to ₹400 million, supported by a diversified product portfolio and deeper market penetration. While annual EBITDA margins saw a slight contraction of 40bps to 10.4%, the company successfully expanded its export footprint into Venezuela, Taiwan, and Sudan. The company is currently scaling its manufacturing capacity at the Barwasni facility to support future growth.
முக்கிய அம்சங்கள்
Full-year FY26 Revenue from Operations increased 19% YoY to ₹7,046 million.Profit After Tax (PAT) for FY26 surged 27% YoY to ₹400 million from ₹315 million.Successfully entered the Latin American market with the first fertilizer shipment to Venezuela.Distribution network strengthened to over 7,000 distributors and 192 active institutional partners.Q4 FY26 Revenue grew 19% YoY to ₹1,508 million, though Q4 EBITDA margins contracted by 300bps to 14%.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's ability to maintain its high double-digit PAT growth and monitor the margin recovery in the upcoming quarters. The expansion into Latin American markets and R&D collaborations suggest a strong long-term growth trajectory in the agrochemical space.
Indogulf Cropsciences Reports Full Compliance in FY26 Annual Secretarial Audit
Indogulf Cropsciences Limited (IGCL) has released its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The audit, conducted by NJ & Associates, confirms that the company has adhered to all applicable SEBI regulations and circulars without any deviations. This marks a significant milestone as it is the company's first full-year compliance report following its listing on July 3, 2025. The report highlights clean records regarding insider trading, board evaluations, and related party transactions.
முக்கிய அம்சங்கள்
Zero deviations or non-compliances reported for the financial year ended March 31, 2026.The company maintained full compliance with SEBI LODR, ICDR, SAST, and Insider Trading regulations.No penalties or adverse actions were taken by SEBI or Stock Exchanges during the review period.Confirmed that no directors are disqualified under Section 164 of the Companies Act, 2013.First annual secretarial report post-listing on July 3, 2025, demonstrating strong initial governance.
👀 கவனிக்க வேண்டியவை
Investors can take confidence in the company's adherence to regulatory frameworks and corporate governance standards. No specific action is required as the report indicates a clean bill of health regarding secretarial and legal compliances.
Indogulf Cropsciences Shareholders Approve Key Director Re-appointments with 99.98% Majority
Indogulf Cropsciences Limited (IGCL) has announced the successful passage of four key resolutions via postal ballot. Shareholders overwhelmingly approved the re-appointment of Mr. Om Prakash Aggarwal as Executive Chairman and Mr. Sanjay Aggarwal as Managing Director, both with 99.98% of valid votes. Additionally, two Independent Directors were re-appointed with similar margins. The high voter turnout, representing approximately 75.94% of the total paid-up capital, reflects strong shareholder confidence in the current leadership.
முக்கிய அம்சங்கள்
Re-appointment of Om Prakash Aggarwal as Executive Chairman approved with 99.98% of valid votes.Sanjay Aggarwal re-appointed as Managing Director with 99.98% shareholder approval.Total voter turnout represented approximately 75.94% of the company's total paid-up capital of 6,32,23,997 shares.Two Independent Directors, Rahul Gupta and Sandeep Bhutani, were also re-appointed with 99.98% majority.
👀 கவனிக்க வேண்டியவை
Investors should view this as a sign of management stability and strong shareholder backing. The continuity in leadership is a positive signal for the company's long-term strategic execution.
Indogulf Cropsciences Proposes 5-Year Re-appointment for Chairman and MD
Indogulf Cropsciences Limited (IGCL) has issued a postal ballot notice to seek shareholder approval for the re-appointment of its top leadership for five-year terms. The company proposes extending the tenures of Executive Chairman Om Prakash Aggarwal and Managing Director Sanjay Aggarwal starting April 1, 2026. Additionally, two Independent Directors, Rahul Gupta and Sandeep Bhutani, are proposed for their second five-year terms. Shareholders can cast their votes via e-voting between February 27 and March 28, 2026.
முக்கிய அம்சங்கள்
Proposed 5-year re-appointment of Om Prakash Aggarwal as Executive Chairman starting April 1, 2026.Proposed 5-year re-appointment of Sanjay Aggarwal as Managing Director starting April 1, 2026.Re-appointment of Independent Directors Rahul Gupta and Sandeep Bhutani for second 5-year terms.E-voting period scheduled from February 27, 2026, to March 28, 2026.Cut-off date for voting eligibility established as February 20, 2026.
👀 கவனிக்க வேண்டியவை
Investors should support these resolutions to ensure management continuity and stability in leadership. Monitor the voting results to confirm the formalization of these appointments.
Indogulf Cropsciences Q3 FY26 Revenue Up 17% YoY; 9M PAT Grows 31% to ₹28 Cr
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to INR 116.1 crore, despite a challenging operating environment and subdued crop prices. For the 9M FY26 period, the company achieved a robust 31% growth in PAT to INR 28 crore, driven by strong performance in the B2B segment (up 26%) and plant nutrition (up 23%). The subsidiary AGPL contributed INR 54 crore in sales during the first nine months, showing successful integration and market acceptance. Management highlighted new export orders from Venezuela, Taiwan, and Sudan worth INR 4-5 crore, expected to boost Q4 performance.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue increased 17% YoY to INR 116.1 crore, while EBITDA rose 16% to INR 11.7 crore.9M FY26 PAT grew by 31% YoY to INR 28 crore, supported by a 19.3% increase in total revenue to INR 553 crore.B2B segment outperformed with 26% YoY growth, while the Plant Nutrition vertical grew by 23% in the 9M period.Subsidiary AGPL achieved gross sales of INR 54 crore in 9M FY26, contributing significantly to overall margins.Secured initial export orders worth INR 4-5 crore from new markets including Venezuela, Taiwan, and Sudan for Q4 execution.
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of the high-margin Plant Nutrition and Biologicals segments, which are currently outperforming traditional crop protection. The successful expansion into international markets and the steady growth of the AGPL subsidiary provide strong catalysts for future growth.
IGCL Q3FY26 Results: Revenue Up 17% YoY to ₹1,161 Mn, 9M PAT Grows 31%
Indogulf Cropsciences (IGCL) reported a resilient Q3FY26 with revenue growing 17% YoY to ₹1,161 Mn and EBITDA rising 16.4% to ₹117 Mn. While Profit Before Tax (PBT) surged 60.2% to ₹74 Mn, Profit After Tax (PAT) saw a more modest growth of 5.6% YoY at ₹39 Mn for the quarter. The nine-month (9M) performance remains robust, with PAT increasing 31.1% YoY to ₹284 Mn. The company also announced a strategic entry into the Venezuela market, with initial orders expected to be executed in Q4 FY26.
முக்கிய அம்சங்கள்
Q3 Revenue from operations increased 17% YoY to ₹1,161 Mn.9M FY26 Profit After Tax (PAT) grew significantly by 31.1% YoY to ₹284 Mn.Profit Before Tax (PBT) for Q3 surged 60.2% YoY to ₹74 Mn from ₹46 Mn.EBITDA for 9M FY26 increased 23.5% YoY to ₹536 Mn, indicating improved operational efficiency.Entered the Venezuela market with initial orders slated for execution in the upcoming quarter (Q4 FY26).
👀 கவனிக்க வேண்டியவை
Investors should note the strong 9-month growth trajectory and the company's expansion into South American markets. Monitor the Q4 execution of Venezuela orders and the impact of domestic monsoon recovery on the agrochemical segment.
Indogulf Cropsciences Q3 FY26 Revenue Up 17% YoY to ₹116 Cr; PBT Surges 60%
Indogulf Cropsciences reported a resilient Q3 FY26 with revenue growing 17% YoY to ₹1,161 million, driven by strong performance in B2B and B2C segments. Despite a challenging environment with subdued crop prices, the company achieved a 60% YoY growth in PBT to ₹74 million. For the 9M FY26 period, revenue and EBITDA grew by 19% and 23% respectively, supported by a 21% revenue contribution from new product launches. The company is expanding its global footprint, recently entering Venezuela and Taiwan, and is utilizing IPO proceeds for debt reduction and a new dry flowable plant.
முக்கிய அம்சங்கள்
Q3 FY26 revenue increased 17% YoY to ₹1,161 million, while 9M FY26 revenue rose 19% to ₹5,538 million.PBT for Q3 FY26 saw a significant jump of 60% YoY to ₹74 million, reflecting improved operational efficiencies.New products launched in the last 3 years contributed 21% to the 9M FY26 revenue, highlighting R&D success.International expansion continues with 34+ countries reached and new market entries in Venezuela and Taiwan.Utilization of ₹1,600 million IPO proceeds is underway for debt reduction and setting up a new dry flowable plant in Haryana.
👀 கவனிக்க வேண்டியவை
Investors should monitor the timely completion of the Barwasni plant expansion and the execution of new export orders from Venezuela. The company's ability to maintain margins despite industry headwinds makes it a strong candidate for long-term agrochemical portfolios.
IGCL Q3 Revenue Up 10% to ₹1,085M; Top Management Re-appointed for 5 Years
Indogulf Cropsciences (IGCL) reported a 10.4% YoY revenue growth in Q3 FY26, reaching ₹1,085.81 million. Net profit for the quarter improved to ₹54.88 million from ₹45.76 million in the same period last year. The board has approved the re-appointment of the Executive Chairman and Managing Director for five-year terms, ensuring leadership stability. For the nine-month period, revenue grew to ₹5,400.09 million, reflecting a healthy upward trajectory compared to the previous year.
முக்கிய அம்சங்கள்
Revenue from operations grew 10.4% YoY to ₹1,085.81 million in Q3 FY26.Net profit for Q3 FY26 increased to ₹54.88 million compared to ₹45.76 million in Q3 FY25.9M FY26 revenue stands at ₹5,400.09 million, up from ₹4,694.57 million YoY.Executive Chairman and Managing Director re-appointed for 5-year terms effective April 2026.Internal Auditor M/s Aditi Gupta & Associates appointed for FY 2025-26.
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the management continuity and steady year-on-year growth. Monitor the company's ability to sustain margins amid fluctuating raw material costs in the agro-chemical sector.
IGCL Q3 PAT Rises 28% YoY to ₹54.9 Million; Re-appoints Top Management for 5 Years
Indogulf Cropsciences Limited (IGCL) reported a steady performance for Q3 FY26, with revenue from operations growing 10.4% YoY to ₹1,085.81 million. Net profit for the quarter saw a robust increase of 27.8% YoY, reaching ₹54.89 million, although EPS remained relatively flat due to an expanded equity base. For the nine-month period ended December 31, 2025, the company achieved a PAT of ₹414.94 million, up from ₹336.44 million in the previous year. The board also ensured leadership continuity by re-appointing the Executive Chairman and Managing Director for five-year terms starting April 2026.
முக்கிய அம்சங்கள்
Revenue from operations increased 10.4% YoY to ₹1,085.81 million in Q3 FY26.Net Profit (PAT) grew by 27.8% YoY to ₹54.89 million for the quarter.9M FY26 Revenue reached ₹5,400.09 million compared to ₹4,694.57 million in 9M FY25.Re-appointed Om Prakash Aggarwal as Executive Chairman and Sanjay Aggarwal as MD for 5-year terms.Paid-up equity share capital stood at ₹632.24 million, up from ₹487.87 million in the year-ago period.
👀 கவனிக்க வேண்டியவை
Investors should view the double-digit profit growth and management continuity as positive signs for long-term stability. The stock's performance may be influenced by the company's ability to maintain margins in the competitive agro-chemical segment.
IGCL Appoints Deepak Tuli as VP-Accounts; Surinder Kumar Resigns as VP-Sales & Marketing
Indogulf Cropsciences Limited (IGCL) has announced key changes to its Senior Management Personnel (SMP) effective December 13, 2025. The company has appointed Mr. Deepak Tuli, a Fellow Chartered Accountant with over 26 years of experience, as the Vice President of Accounts to lead financial strategy and auditing. Concurrently, Mr. Surinder Kumar has resigned from his role as Vice President of Sales & Marketing (North & South zones) due to health challenges. These leadership shifts reflect a strengthening of the finance function while managing a transition in regional sales leadership.
முக்கிய அம்சங்கள்
Appointment of Mr. Deepak Tuli as Vice President - Accounts and Senior Management Personnel effective December 13, 2025.Mr. Deepak Tuli brings over 26 years of experience in financial strategy, taxation, and treasury across the manufacturing sector.Resignation of Mr. Surinder Kumar from the position of Vice President - Sales & Marketing (North & South zones) effective close of business hours on December 13, 2025.Mr. Kumar's resignation was attributed to ongoing health challenges, as per his formal resignation letter.The Board of Directors approved these changes in a meeting held on December 13, 2025, which concluded at 3:00 P.M.
👀 கவனிக்க வேண்டியவை
Investors should monitor the transition in the Sales & Marketing department to ensure regional performance in the North and South zones remains stable. The appointment of a highly experienced finance professional is a positive sign for the company's internal controls and financial reporting.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
